Simply and sensitively simultaneous detection hepatocellular carcinoma markers AFP and miRNA-122 by a label-free resonance light scattering sensor

被引:45
作者
Chen, Feng [1 ]
Zhang, Feng [2 ]
Liu, Yi [1 ]
Cai, Changqun [1 ]
机构
[1] Xiangtan Univ, Coll Chem, Key Lab Green Organ Synth & Applicat Hunan Prov, Key Lab Environm Friendly Chem & Applicat,Minist, Xiangtan 411105, Peoples R China
[2] Hunan Agr Univ, Coll Sci, Changsha 410128, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Simultaneous detection; AFP; miRNA; Bifunctional; Label-free; ALPHA-FETOPROTEIN; TUMOR-MARKERS; ELECTROCHEMICAL IMMUNOSENSOR; CANCER; IMMUNOASSAY; NANOCOMPOSITES; FLUORESCENCE; BIOMARKERS; MICRORNAS;
D O I
10.1016/j.talanta.2018.04.060
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this study, an intelligent and label-free sensor is utilized for the first time to one-spot simultaneous detection hepatocellular carcinoma markers AFP and miRNA-122 by a resonance light scattering (RLS) sensor. cDNA1 hybridizes with cDNA2 to form double-stranded DNA (dsDNA). The construction of dsDNA and methyl violet is used to form the RLS sensor via the electronic interaction. When AFP or miRNA-122 is present, the cDNA (cDNA1 or cDNA2) can bindings of target, thereby RLS intensity changed proportionally with the concentration of AFP or that of miRNA-122. The detection limits of AFP and miRNA-122 are 0.94 mu g/L and 98 pM respectively, and their good linear which ranges from 5 to 100 mu g/L and 200 pM to 10 nM are achieved using the assay. In the presence of miRNA-122 and AFP mixtures, AFP bound to the AFP aptamer to increase the RLS signal, and miRNA-122 bound to the miRNA-122 complementary strand to decrease the RLS signal. The RLS signal changed in response to changing AFP and miRNA-122 concentrations, so that one-spot simultaneous detection of alpha fetal protein and miRNA-122 is achieved. This method has potential practical applications in the research of hepatocellular carcinoma.
引用
收藏
页码:473 / 480
页数:8
相关论文
共 34 条
[1]   POLY(DA).POLY(DT) IS A B-TYPE DOUBLE HELIX WITH A DISTINCTIVELY NARROW MINOR GROOVE [J].
ALEXEEV, DG ;
LIPANOV, AA ;
SKURATOVSKII, IY .
NATURE, 1987, 325 (6107) :821-823
[2]   Aptamers switch on fluorescence of triphenylmethane dyes [J].
Babendure, JR ;
Adams, SR ;
Tsien, RY .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (48) :14716-14717
[3]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[4]  
Chang T.-S., 2015, AM J GASTROENTEROL, V110, P1
[5]   ALPHA-FETOPROTEIN PRODUCING EARLY GASTRIC-CANCER WITH LIVER METASTASIS - REPORT OF 3 CASES [J].
CHANG, YC ;
NAGASUE, N ;
ABE, S ;
KOHNO, H ;
KUMAR, DD ;
NAKAMURA, T .
GUT, 1991, 32 (05) :542-545
[6]   Electrochemical immunosensor for simultaneous detection of multiplex cancer biomarkers based on graphene nanocomposites [J].
Chen, Xia ;
Jia, Xinle ;
Han, Jingman ;
Ma, Jie ;
Ma, Zhanfang .
BIOSENSORS & BIOELECTRONICS, 2013, 50 :356-361
[7]   Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial [J].
Di Bisceglie, AM ;
Sterling, RK ;
Chung, RT ;
Everhart, JE ;
Dienstag, JL ;
Bonkovsky, HL ;
Wright, EC ;
Everson, GT ;
Lindsay, KL ;
Lok, ASF ;
Lee, WM ;
Morgan, TR ;
Ghany, MG ;
Gretch, DR .
JOURNAL OF HEPATOLOGY, 2005, 43 (03) :434-441
[8]   Serum tumor markers in breast cancer: Are they of clinical value? [J].
Duffy, MJ .
CLINICAL CHEMISTRY, 2006, 52 (03) :345-351
[9]   STRUCTURAL COMPARISON OF ANTICANCER DRUG DNA COMPLEXES - ADRIAMYCIN AND DAUNOMYCIN [J].
FREDERICK, CA ;
WILLIAMS, LD ;
UGHETTO, G ;
VANDERMAREL, GA ;
VANBOOM, JH ;
RICH, A ;
WANG, AHJ .
BIOCHEMISTRY, 1990, 29 (10) :2538-2549
[10]   Channel and substrate zone two-dimensional resolution for chemiluminescent multiplex immunoassay [J].
Fu, Zhifeng ;
Yang, Zhanjun ;
Tang, Jinhai ;
Liu, Hong ;
Yan, Feng ;
Ju, Huangxian .
ANALYTICAL CHEMISTRY, 2007, 79 (19) :7376-7382